The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Dr. Niti Navanimitkul, MD, from the Urology Center at Bangkok Hospital Pattaya gave an informative presentation to the ...

People with obesity, as well as those with kidney or liver disease, are more likely to suffer with bad odour. Some medicines ...

Several conditions can lead to urinary flow problems. In men, prostate changes often affect urination patterns, particularly ...

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...

Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

The drop in temperature during winter can tighten the pelvic organ reducing the blood flow ( vasoconstriction). This can ...

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...